Diagnocure announces the formation of a new Strategic Advisory Board
The Strategic Advisory Board is composed of Dr. Edith Mitchell, MD, FACP, Clinical Professor of Medicine & Medical Oncology at Jefferson Kimmel Cancer Center; Dr. Stanley R. Hamilton, MD, Professor and Head, Division of Pathology & Laboratory Medicine at the MD Anderson Cancer Center; Dr. Daniel J. Sargent, Ph.D., Professor of Statistics and Oncology and Director of Cancer Statistics at Mayo Clinic; Dr. Martin R. Weiser, MD, Surgical Oncologist at the Memorial Sloan-Kettering Cancer Center. Their mandate consists of advising the Company on a number of issues related to Previstage(TM) GCC and the Company's commercialization efforts.
"DiagnoCure is proud to count on these top renowned specialists to provide critical input on the positioning of the test and its future improvements," stated John Schafer, President and CEO of DiagnoCure.
Most read news
Topics
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.